<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.3.1" -->
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>
<channel>
	<title>Comments on: The &#8220;Naked&#8221; Truth About Antibodies For Cancer Therapy- Part I</title>
	<link>http://www.hammerstockblog.com/the-naked-truth-about-antibodies-for-cancer-therapy/</link>
	<description>Biotech stock reviews</description>
	<pubDate>Tue, 07 Feb 2012 17:53:47 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.3.1</generator>
		<item>
		<title>By: Immunogen: Another Step Closer to FDA Approval &#124; Global Investors</title>
		<link>http://www.hammerstockblog.com/the-naked-truth-about-antibodies-for-cancer-therapy/#comment-1482</link>
		<dc:creator>Immunogen: Another Step Closer to FDA Approval &#124; Global Investors</dc:creator>
		<pubDate>Tue, 18 May 2010 17:20:19 +0000</pubDate>
		<guid>http://www.hammerstockblog.com/the-naked-truth-about-antibodies-for-cancer-therapy/#comment-1482</guid>
		<description>[...] becoming a focal point in the pharmaceutical industry can be found in some previous entries here, here and [...]</description>
		<content:encoded><![CDATA[<p>[&#8230;] becoming a focal point in the pharmaceutical industry can be found in some previous entries here, here and [&#8230;]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

